ZyCoV-D showed safety and efficacy in a late-stage trial with more than 28,000 volunteers, including subjects in the 12-18 year age group
01 Jul 2021 9:06 AM
Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India
27 Jul 2020 3:21 PM